A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung Cancer
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
Objectives:
1. Primary Objective:
To bridge the data of efficacy in term of overall response rate of TS-1 plus cisplatin
in Taiwanese advanced NSCLC patients from that gained from Japanese population
2. Secondary Objectives:
A. To assess progression free survival B. To assess overall survival C. To bridge the safety
profile by assessing the toxicities and tolerability